Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis

Annals of Oncology

Volumn 26, Issue 5, 2015, Pages 902-907

  Janssen Heijnen, M L G ^a,b   Van Erning, F N ^c   De Ruysscher, D K ^d   Coebergh, J W W ^c,e   Groen, H J M ^f  

^a VIECURI MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c The Netherlands   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Causes of death; Conditional survival; Excess mortality; Long term; Non small cell lung cancer

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE; VERY ELDERLY; AGE; AGE DISTRIBUTION; CARCINOMA, NON-SMALL-CELL LUNG; CARDIOVASCULAR DISEASES; EPIDEMIOLOGY; LUNG NEOPLASMS; MORTALITY; NETHERLANDS; PATHOLOGY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTER; TIME FACTOR;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; TIME FACTORS;

EID: 84929078773     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdv061     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403.
3. van der Drift MA, Karim-Kos HE, Siesling S et al. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol 2012; 7: 291-298.
4. Janssen-Heijnen ML, van Steenbergen LN, Steyerberg E et al. Long-term excess mortality for survivors of non-small cell lung cancer in the Netherlands. J Thorac Oncol 2012; 7: 496-502.
5. Baade PD, Youlden DR, Chambers SK. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 2011; 194: 73-77.
6. Bouvier AM, Remontet L, Hedelin G et al. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis. Cancer 2009; 115: 4616-4624.
7. Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist 2010; 15: 873-882.
8. Skuladottir H, Olsen JH. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 2003; 21: 3035-3040.
9. Wang SJ, Fuller CD, Thomas CR Jr. Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol 2007; 2: 180-190.
10. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br Med J 1994; 309: 901-911.
11. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993; 22: 369-376.
12. Janssen-Heijnen ML, Smulders S, Lemmens VE et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004; 59: 602-607.
13. Skaug K, Eide GE, Gulsvik A. Predictors of long-term survival of lung cancer patients in a Norwegian community. Clin Respir J 2011; 5: 50-58.
14. Hubbard MO, Fu P, Margevicius S, Dowlati A, Linden PA. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10-to 18-year survival. J Thorac Cardiovasc Surg 2012; 143: 1307-1313.
15. Nichols L, Saunders R, Knollmann FD. Causes of death of patients with lung cancer. Arch Pathol Lab Med 2012; 136: 1552-1557.
16. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. J Am Med Assoc 2004; 291: 2441-2447.
17. Read WL, Tierney RM, Page NC et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004; 22: 3099-3103.
18. Dell'Amore A, Monteverde M, Martucci N et al. Early and long-term results of pulmonary resection for non-small-cell lung cancer in patients over 75 years of age: a multi-institutional study. Interact Cardiovasc Thorac Surg 2013; 16: 250-256.
19. Jorgensen TL, Hallas J, Friis S, Herrstedt J. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 2012; 106: 1353-1360.
20. Powell HA, Iyen-Omofoman B, Baldwin DR, Hubbard RB, Tata LJ. Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis. J Thorac Oncol 2013; 8: e34-e35.
21. Williams CD, Stechuchak KM, Zullig LL, Provenzale D, Kelley MJ. Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer. J Clin Oncol 2013; 31: 475-481.
22. Piccirillo JF, Vlahiotis A, Barrett LB et al. The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 2008; 67: 124-132.
23. Wanders R, Steevens J, Botterweck A et al. Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study. Eur J Cancer 2011; 47: 2691-2697.
24. Phernambucq EC, Spoelstra FO, Verbakel WF et al. Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. Ann Oncol 2011; 22: 132-138.
25. Butts CA, Ding K, Seymour L et al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-smallcell lung cancer: updated survival analysis of JBR-10. J Clin Oncol 2010; 28: 29-34.
26. Groth SS, Rueth NM, Hodges JS et al. Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer. Ann Thorac Surg 2010; 90: 375-382.
27. Vaartjes I, O'Flaherty M, Grobbee DE, Bots ML, Capewell S. Coronary heart disease mortality trends in the Netherlands 1972-2007. Heart 2011; 97: 569-573.
28. Chuang SC, Scelo G, Lee YC et al. Risks of second primary cancer among patients with major histological types of lung cancers in both men and women. Br J Cancer 2010; 102: 1190-1195.
29. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998; 90: 1335-1345.
30. Duchateau CS, Stokkel MP. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival. Chest 2005; 127: 1152-1158.
31. Tabuchi T, Ito Y, Ioka A et al. Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study. Ann Oncol 2013; 24: 2699-2704.
32. Schmidt-Hansen M, Baldwin DR, Hasler E. What is the most effective follow-up model for lung cancer patients? A systematic review. J Thorac Oncol 2012; 7: 821-824.
33. Vansteenkiste J, De Ruysscher D, Eberhardt WE et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi89-vi98.
34. Aberle DR, Abtin F, Brown K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol 2013; 31: 1002-1008.
35. Aberle DR, Adams AM, Berg CD et al. Reduced lung-cancer mortality with lowdose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
36. van Klaveren RJ, Oudkerk M, Prokop M et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361: 2221-2229.
37. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. Br Med J 2010; 340: b5569.
38. Harteloh P, de Bruin K, Kardaun J. The reliability of cause-of-death coding in the Netherlands. Eur J Epidemiol 2010; 25: 531-538.